# David Langleben

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-langleben/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,935 |
| Field | Pulmonary Hypertension Research and Treatments |
| h-index | 49 |
| i10-index | 121 |
| Last Known Institution | Jewish General Hospital |
| OpenAlex ID | https://openalex.org/A5013077384 |
| ORCID iD | https://orcid.org/0000-0002-6495-0094 |
| Works | 267 |

## Researcher papers

- [A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension](https://scholariq.org/papers/a-comparison-of-continuous-intravenous-epoprostenol-prostacyclin-with/)
- [Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension](https://scholariq.org/papers/expression-of-endothelin-1-in-the-lungs-of-patients-with-pulmonary-hypertension/)
- [Riociguat for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/riociguat-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease](https://scholariq.org/papers/continuous-intravenous-epoprostenol-for-pulmonary-hypertension-due-to-the/)
- [Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension](https://scholariq.org/papers/effects-of-long-term-infusion-of-prostacyclin-epoprostenol-on-echocardiographic/)
- [Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial](https://scholariq.org/papers/switching-to-riociguat-versus-maintenance-therapy-with-phosphodiesterase-5/)

## Researcher topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Researcher university

- [Jewish General Hospital](https://scholariq.org/institutions/jewish-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
